Access our complete catalogue of cancer immunotherapy clinical practice guidelines using the SITC CPG Mobile App.
SITC is pleased to announce the publication of the nonmelanoma skin cancer clinical practice guideline (CPG). The recommendations in this guideline will provide a valuable clinical decision-making tool to help guide oncologists and other advanced practice providers in the treatment of patients with nonmelanoma skin cancer (NMSC).
Reflecting the evolving therapeutic landscape, SITC has developed an NMSC CPG with topics including selection of appropriate immunotherapeutic regimens, recognition and management of adverse events, and patient quality of life considerations. The manuscript, the latest in the ongoing series of SITC Cancer Immunotherapy Guidelines, is available now in the Journal for ImmunoTherapy of Cancer (JITC), the society’s open access, peer-reviewed online journal.
The SITC Cancer Immunotherapy Guidelines program is a collection of CPGs developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a balanced group including academic physicians and researchers, nurses, patients, and patient advocates. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals. Each expert panel addresses knowledge gaps in general understanding of the optimal clinical use of immunotherapy to offer practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients.
SITC is hosting free webinars featuring Expert Panel members from SITC's Nonmelanoma Skin Cancer Immunotherapy Guideline. These educational offerings are designed for healthcare providers who treat cancer patients including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants. The live webinars include a dedicated question-and-answer session providing the opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.
Christopher A. Barker, MD — Memorial Sloan Kettering Cancer Center
Shailender Bhatia, MD — Fred Hutchinson Cancer Research Center, University of Washington
Kathryn B. Bollin, MD — Scripps MD Anderson Cancer Center
Sunandana Chandra, MD, MS — Northwestern University Feinberg School of Medicine
Zeynep Eroglu, MD — H. Lee Moffitt Cancer Center & Research Institute
Brian R. Gastman, MD — Cleveland Clinic Cancer Center
Kari L. Kendra, MD, PhD — The Ohio State University Comprehensive Cancer Center
Harriet Kluger, MD — Yale University
Evan J. Lipson, MD — Johns Hopkins University
Kathleen Madden, FNP, MSN, AOCNP, APHN — NYU Langone Perlmutter Cancer Center
David M. Miller, MD, PhD, FAAD — Massachusetts General Hospital
Paul Nghiem, MD, PhD — University of Washington
Anna C. Pavlick, DO, MBA — Weill Cornell Medicine
Igor Puzanov, MD, MSci, FACP — Roswell Park Comprehensive Cancer Center
Guilherme Rabinowits, MD — Miami Cancer Institute
Emily S. Ruiz, MD, MPH — Brigham and Women's Hospital
Vernon K. Sondak, MD — Moffitt Cancer Center & Research Institute
Edward Tavss, PhD — Patient
Michael T. Tetzlaff, MD, PhD — University of California, San Francisco
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org